LD-2 disclosure · Registration
ORPHAZYME US, INC.
Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.
Client
- Name
- ORPHAZYME US, INC.
- Description
- Development of Heat-Shock Protein response for treatment of neurodegenerative rare disease
- Location
- Illinois · United States of America
Registrant
- Description
- lobby firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act
LobbyistsPATROSKI LAWSON · BENJAMIN MASON · KATHERINE LANDES
Covered position (BENJAMIN MASON): Communications Director, Rep. David Young January 2017 - June 2017
Pharmacy
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act
LobbyistsPATROSKI LAWSON · BENJAMIN MASON · KATHERINE LANDES
Covered position (BENJAMIN MASON): Communications Director, Rep. David Young January 2017 - June 2017